
Ralph J. Gitomer
Examiner (ID: 10080, Phone: (571)272-0916 , Office: P/1657 )
| Most Active Art Unit | 1657 |
| Art Unit(s) | 1803, 2899, 1651, 1657, 1815, 1655, 1627, 1623, 1622, 1211 |
| Total Applications | 3335 |
| Issued Applications | 2109 |
| Pending Applications | 286 |
| Abandoned Applications | 943 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7208643
[patent_doc_number] => 20050043510
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-24
[patent_title] => 'Affinity purification system using troponin molecules as affinity ligands'
[patent_app_type] => utility
[patent_app_number] => 10/820998
[patent_app_country] => US
[patent_app_date] => 2004-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 18348
[patent_no_of_claims] => 66
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0043/20050043510.pdf
[firstpage_image] =>[orig_patent_app_number] => 10820998
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/820998 | Affinity purification system using troponin molecules as affinity ligands | Apr 6, 2004 | Abandoned |
Array
(
[id] => 737955
[patent_doc_number] => 07034117
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-04-25
[patent_title] => 'RAD51 polypeptides and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/818809
[patent_app_country] => US
[patent_app_date] => 2004-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25089
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/034/07034117.pdf
[firstpage_image] =>[orig_patent_app_number] => 10818809
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/818809 | RAD51 polypeptides and uses thereof | Apr 5, 2004 | Issued |
Array
(
[id] => 5596295
[patent_doc_number] => 20060160212
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-20
[patent_title] => 'Process for isolating haemocyanin'
[patent_app_type] => utility
[patent_app_number] => 10/548609
[patent_app_country] => US
[patent_app_date] => 2004-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3261
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20060160212.pdf
[firstpage_image] =>[orig_patent_app_number] => 10548609
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/548609 | Process for isolating haemocyanin | Mar 25, 2004 | Abandoned |
Array
(
[id] => 7428623
[patent_doc_number] => 20040161825
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-19
[patent_title] => 'Sperm specific proteins'
[patent_app_type] => new
[patent_app_number] => 10/809655
[patent_app_country] => US
[patent_app_date] => 2004-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 14943
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0161/20040161825.pdf
[firstpage_image] =>[orig_patent_app_number] => 10809655
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/809655 | Sperm specific proteins | Mar 24, 2004 | Issued |
Array
(
[id] => 7328125
[patent_doc_number] => 20040253597
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-16
[patent_title] => 'Novel protein and dna thereof'
[patent_app_type] => new
[patent_app_number] => 10/490080
[patent_app_country] => US
[patent_app_date] => 2004-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 30684
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0253/20040253597.pdf
[firstpage_image] =>[orig_patent_app_number] => 10490080
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/490080 | Novel protein and dna thereof | Mar 16, 2004 | Abandoned |
Array
(
[id] => 7419632
[patent_doc_number] => 20040228926
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-18
[patent_title] => 'Methods for treating cancer using perna canaliculus component(S) and extracts of perna canaliculus'
[patent_app_type] => new
[patent_app_number] => 10/800016
[patent_app_country] => US
[patent_app_date] => 2004-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 4570
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0228/20040228926.pdf
[firstpage_image] =>[orig_patent_app_number] => 10800016
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/800016 | Methods for treating cancer using perna canaliculus component(S) and extracts of perna canaliculus | Mar 14, 2004 | Abandoned |
| 10/795766 | Novel human gene with immunoregulatory and anti-proliferative properties | Mar 7, 2004 | Abandoned |
Array
(
[id] => 5656486
[patent_doc_number] => 20060142222
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-29
[patent_title] => 'Novel gene relating to fibrotic conditions'
[patent_app_type] => utility
[patent_app_number] => 10/547710
[patent_app_country] => US
[patent_app_date] => 2004-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 17425
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20060142222.pdf
[firstpage_image] =>[orig_patent_app_number] => 10547710
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/547710 | Novel gene relating to fibrotic conditions | Mar 2, 2004 | Abandoned |
Array
(
[id] => 699678
[patent_doc_number] => 07067633
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-06-27
[patent_title] => 'Targeting cellular entry, cell survival, and pathogenicity by dynein light chain 1/PIN in human cells'
[patent_app_type] => utility
[patent_app_number] => 10/787603
[patent_app_country] => US
[patent_app_date] => 2004-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 23
[patent_no_of_words] => 56684
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/067/07067633.pdf
[firstpage_image] =>[orig_patent_app_number] => 10787603
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/787603 | Targeting cellular entry, cell survival, and pathogenicity by dynein light chain 1/PIN in human cells | Feb 25, 2004 | Issued |
Array
(
[id] => 715128
[patent_doc_number] => 07052870
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-05-30
[patent_title] => 'mTOR kinase-associated proteins'
[patent_app_type] => utility
[patent_app_number] => 10/782244
[patent_app_country] => US
[patent_app_date] => 2004-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 27
[patent_no_of_words] => 23272
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/052/07052870.pdf
[firstpage_image] =>[orig_patent_app_number] => 10782244
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/782244 | mTOR kinase-associated proteins | Feb 17, 2004 | Issued |
Array
(
[id] => 7088541
[patent_doc_number] => 20050008653
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-13
[patent_title] => 'Stabilizing molecule'
[patent_app_type] => utility
[patent_app_number] => 10/775679
[patent_app_country] => US
[patent_app_date] => 2004-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 17789
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20050008653.pdf
[firstpage_image] =>[orig_patent_app_number] => 10775679
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/775679 | Stabilizing molecule | Feb 9, 2004 | Abandoned |
Array
(
[id] => 7255910
[patent_doc_number] => 20040259781
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-23
[patent_title] => 'Anti-tumour agents and methods of identifying anti-tumour agents'
[patent_app_type] => new
[patent_app_number] => 10/485924
[patent_app_country] => US
[patent_app_date] => 2004-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14736
[patent_no_of_claims] => 68
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0259/20040259781.pdf
[firstpage_image] =>[orig_patent_app_number] => 10485924
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/485924 | Anti-tumour agents and methods of identifying anti-tumour agents | Feb 2, 2004 | Abandoned |
Array
(
[id] => 7325104
[patent_doc_number] => 20040138132
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-15
[patent_title] => 'Membrane translocating peptide drug delivery system'
[patent_app_type] => new
[patent_app_number] => 10/764235
[patent_app_country] => US
[patent_app_date] => 2004-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11253
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0138/20040138132.pdf
[firstpage_image] =>[orig_patent_app_number] => 10764235
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/764235 | Membrane translocating peptide drug delivery system | Jan 22, 2004 | Issued |
Array
(
[id] => 7673364
[patent_doc_number] => 20040180415
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-16
[patent_title] => 'Methods and compositions for protein purification'
[patent_app_type] => new
[patent_app_number] => 10/762588
[patent_app_country] => US
[patent_app_date] => 2004-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 15482
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0180/20040180415.pdf
[firstpage_image] =>[orig_patent_app_number] => 10762588
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/762588 | Methods and compositions for protein purification | Jan 20, 2004 | Abandoned |
Array
(
[id] => 7311104
[patent_doc_number] => 20040143113
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-22
[patent_title] => 'Novel human thrombospondin repeat proteins and polynucleotides encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/760783
[patent_app_country] => US
[patent_app_date] => 2004-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7779
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20040143113.pdf
[firstpage_image] =>[orig_patent_app_number] => 10760783
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/760783 | Novel human thrombospondin repeat proteins and polynucleotides encoding the same | Jan 19, 2004 | Abandoned |
Array
(
[id] => 6990922
[patent_doc_number] => 20050089959
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-28
[patent_title] => 'Novel Bacillus thuringiensis strain, crystal gene and crystal protein and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/756778
[patent_app_country] => US
[patent_app_date] => 2004-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 10535
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0089/20050089959.pdf
[firstpage_image] =>[orig_patent_app_number] => 10756778
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/756778 | Bacillus thuringiensis strain, crystal gene and crystal protein and uses thereof | Jan 13, 2004 | Issued |
Array
(
[id] => 7318828
[patent_doc_number] => 20040224886
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-11
[patent_title] => 'Stabilized compositions comprising tissue factor pathway inhibitor protein or tissue factor pathway inhibitor variant proteins'
[patent_app_type] => new
[patent_app_number] => 10/753068
[patent_app_country] => US
[patent_app_date] => 2004-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11541
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20040224886.pdf
[firstpage_image] =>[orig_patent_app_number] => 10753068
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/753068 | Stabilized compositions comprising tissue factor pathway inhibitor protein or tissue factor pathway inhibitor variant proteins | Jan 7, 2004 | Abandoned |
Array
(
[id] => 668515
[patent_doc_number] => 07094756
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-08-22
[patent_title] => 'Abin-mediated hepatitis protection'
[patent_app_type] => utility
[patent_app_number] => 10/741923
[patent_app_country] => US
[patent_app_date] => 2003-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 11
[patent_no_of_words] => 9454
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/094/07094756.pdf
[firstpage_image] =>[orig_patent_app_number] => 10741923
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/741923 | Abin-mediated hepatitis protection | Dec 18, 2003 | Issued |
Array
(
[id] => 7190097
[patent_doc_number] => 20040204354
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-14
[patent_title] => 'Artificial low-density lipoprotein carriers for transport of substances across the blood-brain barrier'
[patent_app_type] => new
[patent_app_number] => 10/724833
[patent_app_country] => US
[patent_app_date] => 2003-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10931
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20040204354.pdf
[firstpage_image] =>[orig_patent_app_number] => 10724833
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/724833 | Artificial low-density lipoprotein carriers for transport of substances across the blood-brain barrier | Dec 1, 2003 | Issued |
Array
(
[id] => 7323928
[patent_doc_number] => 20040137579
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-15
[patent_title] => 'Protein complexes having factor VIII:C activity and production thereof'
[patent_app_type] => new
[patent_app_number] => 10/726199
[patent_app_country] => US
[patent_app_date] => 2003-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14978
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20040137579.pdf
[firstpage_image] =>[orig_patent_app_number] => 10726199
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/726199 | Protein complexes having factor VIII:C activity and production thereof | Nov 30, 2003 | Abandoned |